Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Sandoz-biosimilar-filgrastim-recommended-for-approval-by-FDA-Oncologic-Drugs-Advisory-Com-19629750/?utm_source=whatsapp&utm_medium=social&utm_campaign=share